入院高血糖与缺血性卒中血管内治疗后不良结局相关
基于MR CLEAN登记研究,纳入2908例前循环大血管闭塞接受血管内治疗的成人患者,评估入院血糖与90天改良Rankin量表评分、症状性颅内出血及成功再灌注的关联。高血糖(入院血糖≥7.8 mmol/L)与功能结局变差、死亡率升高及症状性颅内出血风险增加相关,且血糖与不良结局呈J型关联。
要点
- 入院高血糖(≥7.8 mmol/L)与血管内治疗后90天功能结局变差独立相关。
- 高血糖患者死亡率(40% vs 23%)及症状性颅内出血风险(9% vs 5%)更高。
- 血糖与不良结局呈J型关联,成功再灌注未改变血糖与结局的关联。
核心结论
- 入院血糖升高与血管内治疗后不良功能结局及症状性颅内出血风险增加相关。
研究设计与样本
- 基于MR CLEAN登记研究的回顾性队列分析,纳入2908例前循环大血管闭塞接受血管内治疗的成人患者。
主要发现
- 中位入院血糖为6.8 mmol/L(IQR 5.9-8.1),882例(30%)存在高血糖。
- 高血糖组中位mRS为4 vs 3,校正共同OR 1.69(95%CI 1.44-1.99)。
- 高血糖组死亡率40% vs 23%,校正OR 1.95(95%CI 1.60-2.38)。
- 高血糖组症状性颅内出血率9% vs 5%,校正OR 1.94(95%CI 1.41-2.66)。
- 血糖与不良结局(mRS 3-6)呈J型关联,高血糖与成功再灌注率无关。
关键数值与推荐
- 高血糖定义为入院血糖≥7.8 mmol/L。
- 成功再灌注定义为eTICI 2b-3。
临床怎么用
- 对血管内治疗患者应关注入院血糖水平,高血糖提示预后不良及出血风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: High-serum glucose on admission is a predictor of poor outcome after stroke. We assessed the association between glucose concentrations and clinical outcomes in patients who underwent endovascular treatment. METHODS: From the MR CLEAN Registry, we selected consecutive adult patients with a large vessel occlusion of the anterior circulation who underwent endovascular treatment and for whom admission glucose levels were available. We assessed the association between admission glucose and the modified Rankin Scale score at 90 days, symptomatic intracranial hemorrhage and successful reperfusion rates. Hyperglycemia was defined as admission glucose ≥7.8 mmol/L. We evaluated the association between glucose and modified Rankin Scale using multivariable ordinal logistic regression and assessed whether successful reperfusion (extended Thrombolysis in Cerebral Infarction 2b-3) modified this association. RESULTS: Of 3637 patients in the MR CLEAN Registry, 2908 were included. Median admission glucose concentration was 6.8 mmol/L (interquartile range, 5.9-8.1) and 882 patients (30%) had hyperglycemia. Hyperglycemia on admission was associated with a shift toward worse functional outcome (median modified Rankin Scale score 4 versus 3; adjusted common odds ratio, 1.69 [95% CI, 1.44-1.99]), increased mortality (40% versus 23%; adjusted odds ratio, 1.95 [95% CI, 1.60-2.38]), and an increased risk of symptomatic intracranial hemorrhage (9% versus 5%; adjusted odds ratio, 1.94 [95% CI, 1.41-2.66]) compared with nonhyperglycemic patients. The association between admission glucose levels and poor outcome (modified Rankin Scale score 3-6) was J-shaped. Hyperglycemia was not associated with the rate of successful reperfusion nor did successful reperfusion modify the association between glucose and functional outcome. CONCLUSIONS: Increased admission glucose is associated with poor functional outcome and an increased risk of symptomatic intracranial hemorrhage after endovascular treatment.
引用
- Rinkel LA, Nguyen TTM, Guglielmi V, et al. High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke. Stroke. 2020. PMID: 33054674. doi:10.1161/STROKEAHA.120.029944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。